Intranasal corticosteroids do not affect intraocular pressure or lens opacity: a systematic review of controlled trials
Rhinology | 16 Aug 2015
N Ahmadi, K Snidvongs, L Kalish, R Sacks, K Tumuluri, G Wilcsek and R Harvey
Intranasal corticosteroids (INCS) are prescribed for the long-term prophylactic treatment of inflammatory upper airway conditions. Although some systemic absorption can occur via topical routes, the clinical relevance is controversial. The effects of orally administered corticosteroids on intraocular pressure (IOP) and lens opacity (LO) are well established, but the impact of the INCS is less well defined. This study aims to systematically review the literature for evidence of adverse occular events with INCS use.
* Data courtesy of Altmetric.com